<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03516643</url>
  </required_header>
  <id_info>
    <org_study_id>01</org_study_id>
    <nct_id>NCT03516643</nct_id>
  </id_info>
  <brief_title>Extracorporeal Shockwave Myocardial Revascularization in Refractory Angina</brief_title>
  <official_title>Improving Myocardial Perfusion in Refractory Angina. Extracorporeal Shockwave Myocardial Revascularization in a Large Prospective Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turin, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turin, Italy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective cohort study to examine the efficacy of ESMR application in patients
      with refractory angina despite optimal medical therapy, not suitable for further PCI or CABG.
      Characteristics such as angina class scores (CCS class score), nitroglycerin consumption and
      hospitalization were compared at baseline and 1, 6 and 12 months after ESMR therapy. The
      effect on cardiac perfusion was assessed at 6 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2009</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of myocardial perfusion</measure>
    <time_frame>6months after ESMR</time_frame>
    <description>Reduction in stress-induced ischemia at SPECT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of symptoms</measure>
    <time_frame>1, 6, 12 months</time_frame>
    <description>Improvement of CCS class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of symptoms</measure>
    <time_frame>1, 6, 12 months</time_frame>
    <description>Improvement of NYHA class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of symptoms</measure>
    <time_frame>1, 6, 12 months</time_frame>
    <description>Reduction of oral nitrates need</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Angina Refractory</condition>
  <condition>Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Shockwave</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extracorporeal Shockwave treatment on Ischemic Myocardium</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Extracorporeal Shockwave Myocardial Revascularization</intervention_name>
    <description>extracorporeal shockwave in ischemic area evaluated by SPECT</description>
    <arm_group_label>Shockwave</arm_group_label>
    <other_name>ESMR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  history of coronary artery disease;

          -  refractory angina pectoris, defined as the persistence of a angina pectoris (Canadian
             Cardiovascular Society class ≥ 2) for more than 3 months, despite the use of optimal
             medical therapy (which included β blockers, calcium channel blockers, long-acting
             nitrates, ivabradine, ranolazine and trimetazidine, up-titrated to the maximal
             tolerated dose) and coronary disease not amenable for further revascularization (as
             determined by an interventional cardiologist and cardiac surgeon);

          -  stable maximal medical therapy for at least 6 weeks;

          -  stress-induced ischemia at baseline SPECT;

          -  left ventricular ejection fraction higher than 40%;

          -  age higher than 18 years.

        Exclusion Criteria:

          -  myocardial infarction or unstable angina in the previous 3 months,

          -  acute myocarditis, pericarditis, left ventricular thrombus, cardiac malignancies,
             chronic pulmonary disease (including emphysema and pulmonary fibrosis), endocarditis

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Alunni</last_name>
    <role>Principal Investigator</role>
    <affiliation>Città della Salute e della Scienza of Torino</affiliation>
  </overall_official>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2018</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2018</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turin, Italy</investigator_affiliation>
    <investigator_full_name>Gianluca Alunni</investigator_full_name>
    <investigator_title>MD, Cardiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

